To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ARFGEF1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
375 supporting clones for gene ARFGEF1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BF513611   ARFGEF1.a 1 to 474 474 to 1   tiling clone,   474/474
(100 %)
2 diff
(99.6 %id)
AW514253 pooled ARFGEF1.a 20 to 439 418 to 1   tiling clone,   418/418
(100 %)
8 diff
(98.1 %id)
DA478337   ARFGEF1.a 270 to 747 2 to 479   capped   478/478
(100 %)
1 diff
(99.8 %id)
DA656239   ARFGEF1.a 294 to 549 2 to 257   capped   256/256
(100 %)
0 diff
(100 %id)
DA438667 tongue, tumor tissue ARFGEF1.a 411 to 989 2 to 580   tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
DA737210   ARFGEF1.a 411 to 931 2 to 521   capped   520/520
(100 %)
1 diff
(99.9 %id)
DA708447   ARFGEF1.a 416 to 981 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
DA648345   ARFGEF1.a 423 to 726 2 to 305   capped   304/304
(100 %)
0 diff
(100 %id)
BF512715   ARFGEF1.a 469 to 952 1 to 484     Submitted on the opposite strand 484/484
(100 %)
0 diff
(100 %id)
BF513131   ARFGEF1.a 469 to 1021 1 to 553     Submitted on the opposite strand 553/554
(99 %)
2 diff
(99.7 %id)
BF513136   ARFGEF1.a 469 to 987 1 to 519     Submitted on the opposite strand 519/519
(100 %)
1 diff
(99.9 %id)
AA411624 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ARFGEF1.a 519 to 700 1 to 182     Submitted on the opposite strand 182/182
(100 %)
7 diff
(96.2 %id)
AA847875 germinal center B cell ARFGEF1.a 519 to 927 1 to 406       406/406
(100 %)
7 diff
(98.3 %id)
AI478658 Kidney ARFGEF1.a 519 to 968 1 to 450     Submitted on the opposite strand 450/450
(100 %)
0 diff
(100 %id)
AI692863 pooled ARFGEF1.a 519 to 1180 1 to 662     Submitted on the opposite strand 662/663
(99 %)
12 diff
(98.2 %id)
AI797683 pooled ARFGEF1.a 519 to 1036 1 to 518     Submitted on the opposite strand 518/525
(98 %)
13 diff
(97.6 %id)
BE048435 Kidney ARFGEF1.a 519 to 1036 1 to 518     Submitted on the opposite strand 518/564
(91 %)
11 diff
(98.1 %id)
NM_006421.3   ARFGEF1.a 519 to 7730 1 to 7212 exact RefSeq,   7212/7212
(100 %)
0 diff
(100 %id)
AA830526 germinal center B cell ARFGEF1.a 543 to 773 1 to 223     Submitted on the opposite strand 223/223
(100 %)
12 diff
(94.7 %id)
AF111162   ARFGEF1.a 768 to 7027 1 to 6259 exact tiling clone,   6259/6259
(100 %)
2 diff
(100.0 %id)
AA121552 brain, neuroepithelial cells ARFGEF1.a 768 to 1278 1 to 521       521/521
(100 %)
11 diff
(97.9 %id)
DA885621   ARFGEF1.a 829 to 1396 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA708091   ARFGEF1.a 835 to 1343 2 to 511   capped   510/510
(100 %)
1 diff
(99.9 %id)
DN990738 brain, whole brain ARFGEF1.a 901 to 1456 9 to 563       555/563
(98 %)
6 diff
(99.0 %id)
AF084520 brain ARFGEF1.a 909 to 6898 1 to 5991 Q233P L620S E1055K     5991/5991
(100 %)
8 diff
(99.9 %id)
BE646516 B-cell, chronic lymphotic leukemia ARFGEF1.a 911 to 1015 1 to 105     Submitted on the opposite strand 105/106
(99 %)
5 diff
(95.3 %id)
DA950899 Spleen ARFGEF1.a 937 to 1513 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BX951412   ARFGEF1.a 949 to 1660 1 to 713       713/713
(100 %)
3 diff
(99.6 %id)
BG187640   ARFGEF1.a 1027 to 1573 1 to 544       542/544
(99 %)
8 diff
(98.6 %id)
BG192215   ARFGEF1.a 1030 to 1578 1 to 547   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 547/551
(99 %)
11 diff
(98.1 %id)
BG195270   ARFGEF1.a 1031 to 1573 1 to 541       541/541
(100 %)
6 diff
(98.9 %id)
BG211322   ARFGEF1.a 1031 to 1802 1 to 774       774/774
(100 %)
21 diff
(97.3 %id)
BG220242   ARFGEF1.a 1032 to 1573 4 to 543       540/543
(99 %)
7 diff
(98.8 %id)
BG217732   ARFGEF1.a 1062 to 1572 1 to 508       508/508
(100 %)
8 diff
(98.5 %id)
AA251624 germinal center B cell ARFGEF1.a 1086 to 1550 473 to 9     Submitted on the opposite strand 465/473
(98 %)
0 diff
(100 %id)
AI468440 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ARFGEF1.a 1144 to 1550 415 to 9       407/415
(98 %)
0 diff
(100 %id)
AW967654   ARFGEF1.a 1152 to 1587 465 to 33     Submitted on the opposite strand 433/465
(93 %)
7 diff
(98.5 %id)
AA410590 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ARFGEF1.a 1167 to 1550 393 to 10     Submitted on the opposite strand 384/393
(97 %)
0 diff
(100 %id)
AI634971 Kidney ARFGEF1.a 1172 to 1550 387 to 9       379/406
(93 %)
0 diff
(100 %id)
BU848779 ovary, teratocarcinoma, cell line ARFGEF1.a 1304 to 1933 1 to 632       632/1109
(56 %)
15 diff
(98.7 %id)
BG400757 Kidney ARFGEF1.a 1431 to 2066 1 to 637       637/637
(100 %)
2 diff
(99.7 %id)
BP352532   ARFGEF1.a 1470 to 2051 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG282317 melanotic melanoma, skin ARFGEF1.a 1534 to 2236 1 to 697       697/861
(80 %)
24 diff
(97.3 %id)
BE082527 breast ARFGEF1.a 1576 to 2021 446 to 1     Submitted on the opposite strand 446/569
(78 %)
1 diff
(99.9 %id)
BQ379416 uterus_tumor ARFGEF1.a 1624 to 1943 481 to 162       320/481
(66 %)
1 diff
(99.8 %id)
FN123192 breast carcinoma ARFGEF1.a 1652 to 1750 98 to 1     Submitted on the opposite strand 98/98
(100 %)
1 diff
(99.0 %id)
AW583148 Islets of Langerhans, Pancreas ARFGEF1.a 1722 to 2190 1 to 469       469/469
(100 %)
4 diff
(99.2 %id)
CK905047 Islets of Langerhans, Pancreas ARFGEF1.a 1722 to 2297 1 to 576       576/576
(100 %)
0 diff
(100 %id)
BF814286 colon_ins ARFGEF1.a 1791 to 2344 17 to 569       553/569
(97 %)
10 diff
(98.3 %id)
BF905700 marrow ARFGEF1.a 1805 to 2025 374 to 154     Submitted on the opposite strand 221/374
(59 %)
0 diff
(100 %id)
AL042131 testis ARFGEF1.a 1908 to 2489 1 to 576     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 576/579
(99 %)
23 diff
(96.1 %id)
BF798176 colon_ins ARFGEF1.a 1934 to 2563 639 to 10     Submitted on the opposite strand 630/640
(98 %)
14 diff
(97.9 %id)
BP312848 mammary gland ARFGEF1.a 1958 to 2541 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BG401991 Kidney ARFGEF1.a 2005 to 2721 1 to 706       706/883
(79 %)
18 diff
(98.0 %id)
CD685893 normal nasopharynx ARFGEF1.a 2016 to 2405 22 to 410       389/410
(94 %)
8 diff
(98.1 %id)
AL713239 human skeletal muscle ARFGEF1.a 2016 to 2563 1 to 549       549/549
(100 %)
5 diff
(99.1 %id)
CF143298 lymph ARFGEF1.a 2043 to 2423 8 to 388       381/388
(98 %)
6 diff
(98.5 %id)
TI_154174617   ARFGEF1.a 2043 to 2645 89 to 690       602/602
(100 %)
7 diff
(98.9 %id)
DB087598 testis ARFGEF1.a 2154 to 2697 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
BQ432290 melanotic melanoma, skin ARFGEF1.a 2160 to 3031 1 to 871       871/890
(97 %)
9 diff
(99.0 %id)
BF983810 duodenal adenocarcinoma, cell line, small intestine ARFGEF1.a 2334 to 3025 1 to 685       685/686
(99 %)
15 diff
(97.9 %id)
BM555616 duodenal adenocarcinoma, cell line, small intestine ARFGEF1.a 2337 to 3325 1 to 1002       1002/1031
(97 %)
16 diff
(98.5 %id)
AL712931 human skeletal muscle ARFGEF1.a 2359 to 2954 1 to 595       595/595
(100 %)
8 diff
(98.7 %id)
BP234069 coronary artery ARFGEF1.a 2430 to 3011 1 to 582       582/583
(99 %)
10 diff
(98.3 %id)
DB321619   ARFGEF1.a 2461 to 3000 540 to 1       540/540
(100 %)
2 diff
(99.7 %id)
DA810437 brain ARFGEF1.a 2475 to 2975 2 to 503   capped   502/502
(100 %)
1 diff
(99.9 %id)
AI863077 brain, tumor, 5 pooled (see description) ARFGEF1.a 2595 to 3002 408 to 1       408/408
(100 %)
1 diff
(99.8 %id)
CD653239 Embryonic Stem cells ARFGEF1.a 2624 to 3346 12 to 731       720/851
(84 %)
12 diff
(98.6 %id)
DB231848 trachea ARFGEF1.a 2697 to 3279 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DW449691 Liver ARFGEF1.a 2726 to 2911 17 to 202       186/202
(92 %)
8 diff
(96.1 %id)
DB071084 testis ARFGEF1.a 2746 to 3268 2 to 525   capped   524/524
(100 %)
1 diff
(99.9 %id)
CD656294 Embryonic Stem cells ARFGEF1.a 2773 to 3476 55 to 755       701/849
(82 %)
16 diff
(98.2 %id)
BE148462 head_neck ARFGEF1.a 2834 to 3168 14 to 348       335/348
(96 %)
6 diff
(98.3 %id)
BE148487 head_neck ARFGEF1.a 2834 to 3351 14 to 531       518/535
(96 %)
9 diff
(98.4 %id)
DA212697 brain ARFGEF1.a 3018 to 3524 2 to 508   capped   507/507
(100 %)
1 diff
(99.9 %id)
DB369795   ARFGEF1.a 3032 to 3556 526 to 1       526/571
(92 %)
8 diff
(98.6 %id)
DA337066 hippocampus ARFGEF1.a 3033 to 3606 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
CD653317 Embryonic Stem cells ARFGEF1.a 3051 to 3875 1 to 820       820/857
(95 %)
12 diff
(98.6 %id)
BX473007   ARFGEF1.a 3075 to 3597 1 to 523       523/525
(99 %)
4 diff
(99.3 %id)
DB065567 testis ARFGEF1.a 3077 to 3606 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
DB068115 testis ARFGEF1.a 3077 to 3619 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
AA121376 brain, neuroepithelial cells ARFGEF1.a 3145 to 3556 416 to 1       416/503
(82 %)
6 diff
(98.9 %id)
DB232290 trachea ARFGEF1.a 3254 to 3828 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DB224044 trachea ARFGEF1.a 3321 to 3897 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
BQ421728 embryonal carcinoma, cell line, testis ARFGEF1.a 3421 to 4274 1 to 859       859/859
(100 %)
11 diff
(98.8 %id)
BX472909   ARFGEF1.a 3479 to 3994 1 to 516       516/516
(100 %)
4 diff
(99.3 %id)
DB062111 testis ARFGEF1.a 3565 to 4090 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DB094475 testis ARFGEF1.a 3565 to 4132 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB088263 testis ARFGEF1.a 3594 to 4152 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BF831920 head_neck ARFGEF1.a 3623 to 3970 1 to 355       355/355
(100 %)
15 diff
(95.8 %id)
BQ354191 head_neck ARFGEF1.a 3637 to 3950 369 to 53       317/369
(85 %)
14 diff
(96.3 %id)
CD655147 Embryonic Stem cells ARFGEF1.a 3752 to 4532 12 to 786       777/795
(97 %)
14 diff
(98.3 %id)
CN370370 embryonic stem cells, cell lines H1, H7, andH9 ARFGEF1.a 3761 to 4001 1 to 241       241/243
(99 %)
5 diff
(98.0 %id)
BP239242 Liver ARFGEF1.a 3811 to 4416 7 to 612       606/612
(99 %)
1 diff
(99.9 %id)
DA776749 brain ARFGEF1.a 3811 to 4381 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DB081088 testis ARFGEF1.a 3848 to 4408 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA231401 brain ARFGEF1.a 3883 to 4417 2 to 537   capped   536/536
(100 %)
3 diff
(99.5 %id)
DB027816 testis ARFGEF1.a 3977 to 4559 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
BM473392 leiomyosarcoma, uterus ARFGEF1.a 3997 to 4707 1 to 715       715/1231
(58 %)
13 diff
(99.0 %id)
DB083909 testis ARFGEF1.a 4009 to 4546 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB087033 testis ARFGEF1.a 4024 to 4598 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB079324 testis ARFGEF1.a 4036 to 4609 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BP359806 mammary gland ARFGEF1.a 4105 to 4685 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA400824 thalamus ARFGEF1.a 4181 to 4746 2 to 567   capped   566/567
(99 %)
2 diff
(99.7 %id)
CF136861 lymph ARFGEF1.a 4241 to 4725 1 to 485       485/485
(100 %)
5 diff
(99.0 %id)
TI_154166082   ARFGEF1.a 4248 to 4893 80 to 731       649/820
(79 %)
16 diff
(98.1 %id)
DA855424 placenta ARFGEF1.a 4275 to 4820 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
BF899744 marrow ARFGEF1.a 4313 to 4727 418 to 1     Submitted on the opposite strand 418/418
(100 %)
17 diff
(96.0 %id)
BQ319441 colon ARFGEF1.a 4329 to 4841 13 to 528       519/528
(98 %)
12 diff
(97.8 %id)
DA798611 brain ARFGEF1.a 4363 to 4911 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BE815401 breast_normal ARFGEF1.a 4384 to 4771 10 to 397       388/397
(97 %)
6 diff
(98.5 %id)
BF327950 breast_normal ARFGEF1.a 4403 to 4743 1 to 340       340/340
(100 %)
5 diff
(98.6 %id)
DA558843   ARFGEF1.a 4415 to 4957 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA994795 synovial membrane tissue from rheumatioidarthritis ARFGEF1.a 4418 to 4971 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
AK022557   ARFGEF1.a 4420 to 7716 1 to 3297   available from FLJ,   3297/3297
(100 %)
1 diff
(100.0 %id)
AU124093   ARFGEF1.a 4421 to 5220 2 to 807   capped   804/806
(99 %)
12 diff
(98.6 %id)
DA992756 synovial membrane tissue from rheumatioidarthritis ARFGEF1.a 4427 to 4956 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
DA404234 thalamus ARFGEF1.a 4429 to 4980 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DB089930 testis ARFGEF1.a 4450 to 5010 2 to 564   capped   563/563
(100 %)
4 diff
(99.3 %id)
BP241695 Liver ARFGEF1.a 4512 to 5093 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA333261 hippocampus ARFGEF1.a 4533 to 5108 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA799203 brain ARFGEF1.a 4535 to 5079 2 to 548   capped   547/547
(100 %)
3 diff
(99.5 %id)
BE928440 colon ARFGEF1.a 4547 to 4734 189 to 2       188/189
(99 %)
2 diff
(99.0 %id)
BE933161 head_neck ARFGEF1.a 4551 to 4985 446 to 15       432/446
(96 %)
1 diff
(99.8 %id)
CA395431 eye, RPE/choroid ARFGEF1.a 4571 to 5110 1 to 540       540/540
(100 %)
0 diff
(100 %id)
DA888123   ARFGEF1.a 4589 to 5148 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DN918068   ARFGEF1.a 4642 to 5278 1 to 633       633/633
(100 %)
18 diff
(97.2 %id)
BF327955 breast_normal ARFGEF1.a 4682 to 5033 355 to 3       353/355
(99 %)
1 diff
(99.8 %id)
BP238527 Liver ARFGEF1.a 4703 to 5300 1 to 598       598/598
(100 %)
3 diff
(99.5 %id)
DB091499 testis ARFGEF1.a 4746 to 5298 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BE258724 eye, retinoblastoma ARFGEF1.a 4818 to 5376 12 to 570       559/570
(98 %)
1 diff
(99.9 %id)
AK001788 ovarian cancer ARFGEF1.a 4875 to 7718 1 to 2844   tiling clone, available from FLJ,   2844/2844
(100 %)
3 diff
(99.9 %id)
AU133701 ovary, tumor tissue ARFGEF1.a 4876 to 5522 2 to 648   capped   647/657
(98 %)
1 diff
(99.9 %id)
BE885228 leiomyosarcoma, uterus ARFGEF1.a 4980 to 5595 1 to 628       628/871
(72 %)
32 diff
(96.4 %id)
BF895934 marrow ARFGEF1.a 4985 to 5246 261 to 1     Submitted on the opposite strand 261/274
(95 %)
4 diff
(98.6 %id)
BP345693 synovial membrane ARFGEF1.a 4999 to 5580 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP346383 synovial membrane ARFGEF1.a 4999 to 5579 1 to 581       581/583
(99 %)
3 diff
(99.5 %id)
DA921203 small intestine ARFGEF1.a 5000 to 5573 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DN918069   ARFGEF1.a 5032 to 5513 483 to 1       483/483
(100 %)
4 diff
(99.2 %id)
BF589985 Kidney ARFGEF1.a 5073 to 5562 530 to 40       491/530
(92 %)
3 diff
(99.5 %id)
AU131774   ARFGEF1.a 5130 to 5966 2 to 841   capped   840/840
(100 %)
4 diff
(99.6 %id)
BG403297 bladder, transitional cell papilloma, cell line ARFGEF1.a 5282 to 5746 1 to 465       465/468
(99 %)
1 diff
(99.8 %id)
DA485871 brain ARFGEF1.a 5286 to 5851 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
AA528449 Ewing's sarcoma ARFGEF1.a 5301 to 5644 344 to 1       344/345
(99 %)
3 diff
(99.2 %id)
DA523388 brain ARFGEF1.a 5340 to 5897 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BP292109 lung ARFGEF1.a 5363 to 5946 1 to 584       584/588
(99 %)
1 diff
(99.9 %id)
CN370371 embryonic stem cells, DMSO-treated H9 cellline ARFGEF1.a 5398 to 5755 1 to 358       358/358
(100 %)
0 diff
(100 %id)
BM423360 amelanotic melanoma, cell line, skin ARFGEF1.a 5399 to 6289 1 to 899       899/1070
(84 %)
21 diff
(98.1 %id)
BM424130 amelanotic melanoma, cell line, skin ARFGEF1.a 5399 to 6362 1 to 984       980/1027
(95 %)
29 diff
(97.2 %id)
DB177702 kidney, tumor tissue ARFGEF1.a 5431 to 5970 2 to 543   capped   542/542
(100 %)
3 diff
(99.5 %id)
DB177713 kidney, tumor tissue ARFGEF1.a 5431 to 5989 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA529099 brain ARFGEF1.a 5452 to 6057 2 to 607   capped   606/606
(100 %)
1 diff
(99.9 %id)
CD653833 Embryonic Stem cells ARFGEF1.a 5494 to 6281 8 to 791       784/794
(98 %)
15 diff
(98.2 %id)
CD652496 Embryonic Stem cells ARFGEF1.a 5494 to 6298 8 to 805       798/848
(94 %)
17 diff
(98.0 %id)
BX479895   ARFGEF1.a 5516 to 5802 1 to 283       281/283
(99 %)
18 diff
(93.7 %id)
BQ716666 sympathetic trunk ARFGEF1.a 5541 to 6291 1 to 749       749/871
(85 %)
3 diff
(99.7 %id)
DA882870   ARFGEF1.a 5589 to 6152 2 to 567   capped   568/566
(100 %)
6 diff
(99.0 %id)
BU940876 mixed (pool of 40 RNAs) ARFGEF1.a 5611 to 6297 1 to 683       683/910
(75 %)
8 diff
(99.2 %id)
BM738457 Ascites, stomach ARFGEF1.a 5628 to 5944 1 to 316       316/316
(100 %)
2 diff
(99.4 %id)
AW846990 colon ARFGEF1.a 5629 to 5859 232 to 1       232/242
(95 %)
2 diff
(99.2 %id)
BP380336 uterus ARFGEF1.a 5643 to 6210 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
DA520523 brain ARFGEF1.a 5669 to 6231 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DB019961 testis ARFGEF1.a 5698 to 6242 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
CB269204 adipose ARFGEF1.a 5715 to 6369 1 to 660       660/663
(99 %)
7 diff
(99.0 %id)
BE890046 leiomyosarcoma, uterus ARFGEF1.a 5725 to 6415 6 to 694       689/932
(73 %)
19 diff
(98.0 %id)
DB204572 trachea ARFGEF1.a 5745 to 6323 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
CN370374 embryonic stem cells, DMSO-treated H9 cellline ARFGEF1.a 5747 to 6431 1 to 685       685/685
(100 %)
0 diff
(100 %id)
BM801115 embryonal carcinoma, cell line, testis ARFGEF1.a 5770 to 6295 1 to 527       527/1016
(51 %)
5 diff
(99.6 %id)
CR998164 T-Lymphocytes ARFGEF1.a 5772 to 6649 1 to 877       877/877
(100 %)
7 diff
(99.3 %id)
BP292713 lung ARFGEF1.a 5826 to 6404 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BG290210 bladder, transitional cell papilloma, cell line ARFGEF1.a 5833 to 6559 1 to 727       727/967
(75 %)
27 diff
(97.3 %id)
CN370373 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ARFGEF1.a 5837 to 6593 9 to 765       757/765
(98 %)
6 diff
(99.3 %id)
CX751454 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass ARFGEF1.a 5846 to 6593 1 to 737     Submitted on the opposite strand 737/843
(87 %)
14 diff
(98.4 %id)
BE813934 breast_normal ARFGEF1.a 5876 to 6216 6 to 347       342/347
(98 %)
6 diff
(98.3 %id)
DA538920 Kidney ARFGEF1.a 5884 to 6466 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
BQ429113 testis ARFGEF1.a 5911 to 6547 1 to 651       651/839
(77 %)
23 diff
(97.3 %id)
DA366566 subthalamic nucleus ARFGEF1.a 5975 to 6533 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BG536892 lung ARFGEF1.a 5992 to 6813 1 to 818       818/820
(99 %)
14 diff
(98.3 %id)
AU134348 ovary, tumor tissue ARFGEF1.a 5998 to 6760 2 to 763   capped   762/762
(100 %)
1 diff
(99.9 %id)
CA389477 eye, RPE/choroid ARFGEF1.a 6059 to 6571 1 to 513       513/513
(100 %)
0 diff
(100 %id)
BI021852 marrow ARFGEF1.a 6070 to 6503 20 to 455       436/458
(95 %)
14 diff
(97.0 %id)
R36291 whole brain ARFGEF1.a 6083 to 6497 1 to 423     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 423/427
(99 %)
14 diff
(96.8 %id)
BI024688 marrow ARFGEF1.a 6084 to 6367 1 to 284       284/284
(100 %)
2 diff
(99.3 %id)
BQ922799 sciatic nerve ARFGEF1.a 6084 to 6913 1 to 835       835/927
(90 %)
10 diff
(99.0 %id)
BF902698 marrow ARFGEF1.a 6085 to 6361 279 to 1     Submitted on the opposite strand 279/279
(100 %)
2 diff
(99.3 %id)
CN370372 embryonic stem cells, DMSO-treated H9 cellline ARFGEF1.a 6114 to 6893 1 to 780       780/780
(100 %)
6 diff
(99.3 %id)
BF904651 marrow ARFGEF1.a 6123 to 6293 1 to 167       167/193
(86 %)
7 diff
(96.4 %id)
CR743615   ARFGEF1.a 6146 to 6645 1 to 500       500/500
(100 %)
0 diff
(100 %id)
BG504705 embryonal carcinoma, testis ARFGEF1.a 6164 to 6838 1 to 676       676/830
(81 %)
4 diff
(99.6 %id)
Z42166 brain, total brain ARFGEF1.a 6179 to 6438 1 to 260       260/260
(100 %)
1 diff
(99.7 %id)
TI_154125201   ARFGEF1.a 6180 to 7028 917 to 80   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 838/966
(86 %)
25 diff
(97.5 %id)
BF210258 bone marrow, from chronic myelogenous leukemia ARFGEF1.a 6224 to 6738 270 to 780       511/953
(53 %)
35 diff
(96.4 %id)
W88930 liver and spleen ARFGEF1.a 6272 to 6666 1 to 399       399/399
(100 %)
5 diff
(98.8 %id)
BG506951 lung ARFGEF1.a 6276 to 6987 1 to 708       708/708
(100 %)
5 diff
(99.3 %id)
AL042132 testis ARFGEF1.a 6477 to 7028 577 to 29   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 549/550
(99 %)
0 diff
(100 %id)
AU153447   ARFGEF1.a 7128 to 7718 590 to 1       590/597
(98 %)
15 diff
(97.5 %id)
AU154934 ovary, tumor tissue ARFGEF1.a 7219 to 7718 499 to 1       499/502
(99 %)
12 diff
(97.7 %id)
DB372006 ovary, tumor tissue ARFGEF1.a 7219 to 7730 523 to 1   tiling clone,   523/523
(100 %)
20 diff
(96.2 %id)
W89187 liver and spleen ARFGEF1.a 7251 to 7700 451 to 3       449/453
(99 %)
0 diff
(100 %id)
R49579 whole brain ARFGEF1.a 7402 to 7718 334 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 318/326
(97 %)
3 diff
(99.1 %id)
Z38425 brain, total brain ARFGEF1.a 7469 to 7730 262 to 1       262/262
(100 %)
0 diff
(100 %id)
AB209324 brain ARFGEF1.b 1 to 5880 2 to 5881 exact tiling clone,   5881/5881
(100 %)
1 diff
(100.0 %id)
BM799497 eye, retinoblastoma ARFGEF1.b 3460 to 4426 1 to 982   AAA   982/1129
(86 %)
25 diff
(97.8 %id)
AI933526 poorly differentiated adenocarcinoma withsignet ring cell features, stomach ARFGEF1.b 3859 to 4192 332 to 1       332/334
(99 %)
11 diff
(96.8 %id)
DB116756 thymus ARFGEF1.b 3917 to 4459 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA949953 Spleen ARFGEF1.b 5209 to 5693 31 to 515   capped   485/514
(94 %)
6 diff
(98.9 %id)
AW295085   ARFGEF1.b 5506 to 5880 393 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 375/375
(100 %)
4 diff
(99.0 %id)
AI288129 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus ARFGEF1.b 5523 to 5894 372 to 1   tiling clone,   372/372
(100 %)
0 diff
(100 %id)
BX092129 liver and spleen ARFGEF1.b 5726 to 6422 1 to 695   tiling clone,   695/695
(100 %)
2 diff
(99.8 %id)
N80474 liver and spleen ARFGEF1.b 5742 to 6115 1 to 374       374/382
(97 %)
10 diff
(97.4 %id)
AW937440 denis_drash ARFGEF1.b 6188 to 6667 1 to 487   tiling clone,   487/487
(100 %)
14 diff
(97.2 %id)
DB333723 Spleen ARFGEF1.b 6652 to 7215 564 to 1       564/565
(99 %)
2 diff
(99.7 %id)
AI743032 pooled ARFGEF1.b 6654 to 7214 562 to 1   tiling clone,   562/562
(100 %)
1 diff
(99.9 %id)
N63628 liver and spleen ARFGEF1.b 6790 to 7219 432 to 1   tiling clone,   432/432
(100 %)
2 diff
(99.6 %id)
AK025637   ARFGEF1.c 1 to 2543 6 to 2548 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2545/2545
(100 %)
0 diff
(100 %id)
DB101005 thymus ARFGEF1.c 1280 to 1785 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
BG497294 lung, mucoepidermoid carcinoma ARFGEF1.c 1758 to 2359 28 to 641       615/641
(95 %)
31 diff
(95.2 %id)
AA304848   ARFGEF1.c 2380 to 2648 1 to 275       275/279
(98 %)
8 diff
(97.2 %id)
BF570891 melanotic melanoma, high MDR, skin ARFGEF1.c 2381 to 3104 1 to 730       730/822
(88 %)
49 diff
(94.1 %id)
BF884400 lung_tumor ARFGEF1.c 2388 to 2770 381 to 1     Submitted on the opposite strand 381/381
(100 %)
3 diff
(99.3 %id)
BE885556 leiomyosarcoma, uterus ARFGEF1.c 2428 to 2989 1 to 570       570/754
(75 %)
13 diff
(98.3 %id)
FN056779 breast carcinoma ARFGEF1.c 2450 to 2544 95 to 1     Submitted on the opposite strand 95/96
(98 %)
0 diff
(100 %id)
CK005653 brain/CNS, Human Brain - Frontal Cortex ARFGEF1.c 2452 to 3127 1 to 674       674/675
(99 %)
4 diff
(99.5 %id)
FN095750 breast carcinoma ARFGEF1.c 2462 to 2552 1 to 91       91/91
(100 %)
6 diff
(93.5 %id)
CA416114 Chondrosarcoma Cell line ARFGEF1.c 2485 to 3104 638 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 620/620
(100 %)
0 diff
(100 %id)
BF107277 placenta ARFGEF1.c 2495 to 3109 1 to 612       612/612
(100 %)
7 diff
(98.9 %id)
W37094 parathyroid gland, parathyroid tumor ARFGEF1.c 2554 to 2822 1 to 269   fully sequenced,   269/269
(100 %)
0 diff
(100 %id)
CB250529 Human Lung Epithelial cells, lung ARFGEF1.c 2555 to 3104 568 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 550/550
(100 %)
0 diff
(100 %id)
H66933 liver and spleen ARFGEF1.c 2559 to 2915 1 to 358       358/358
(100 %)
5 diff
(98.7 %id)
AA037556.
matches multiple genes
uterus ARFGEF1.c 2561 to 3050 1 to 496     also hits gene UBE2Q1 496/496
(100 %)
6 diff
(98.8 %id)
FN078978 breast carcinoma ARFGEF1.c 2575 to 2682 1 to 109       109/109
(100 %)
1 diff
(99.1 %id)
BM992430 Bone, Subchondral Bone ARFGEF1.c 2591 to 3105 532 to 18       515/532
(96 %)
0 diff
(100 %id)
AA037474.
matches multiple genes
uterus ARFGEF1.c 2595 to 3104 514 to 1     also hits gene CHURC1andFNTB 514/515
(99 %)
4 diff
(99.3 %id)
BE709171 head_neck ARFGEF1.c 2604 to 2916 326 to 11       316/349
(90 %)
0 diff
(100 %id)
FN054578 breast carcinoma ARFGEF1.c 2604 to 2711 109 to 1     Submitted on the opposite strand 109/109
(100 %)
2 diff
(98.2 %id)
AI372053 pooled germ cell tumors ARFGEF1.c 2619 to 3105 489 to 3       487/489
(99 %)
0 diff
(100 %id)
AI125675   ARFGEF1.c 2623 to 3105 487 to 5       483/487
(99 %)
0 diff
(100 %id)
FN095603 breast carcinoma ARFGEF1.c 2639 to 2739 1 to 97       97/99
(97 %)
5 diff
(95.0 %id)
H90949 liver and spleen ARFGEF1.c 2651 to 3075 1 to 429       429/429
(100 %)
10 diff
(97.7 %id)
H90489 liver and spleen ARFGEF1.c 2651 to 3098 1 to 460       460/463
(99 %)
14 diff
(97.0 %id)
AA203187 liver and spleen ARFGEF1.c 2651 to 3292 1 to 635       635/877
(72 %)
10 diff
(98.9 %id)
AI376529 pooled ARFGEF1.c 2667 to 3105 441 to 3       439/441
(99 %)
0 diff
(100 %id)
BG678228 skin, squamous cell carcinoma ARFGEF1.c 2687 to 3486 1 to 808       808/811
(99 %)
14 diff
(98.3 %id)
AW135661   ARFGEF1.c 2688 to 3104 434 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 417/417
(100 %)
0 diff
(100 %id)
AI630934 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors ARFGEF1.c 2697 to 3109 412 to 1       412/412
(100 %)
5 diff
(98.8 %id)
AI024526   ARFGEF1.c 2700 to 3087 388 to 1       388/388
(100 %)
1 diff
(99.8 %id)
BG436110 placenta ARFGEF1.c 2702 to 3526 1 to 827       827/832
(99 %)
42 diff
(95.0 %id)
BU171197 melanotic melanoma, skin ARFGEF1.c 2721 to 3654 28 to 961       934/961
(97 %)
6 diff
(99.4 %id)
BE172243 head_neck ARFGEF1.c 2726 to 2861 136 to 1     Submitted on the opposite strand 136/136
(100 %)
0 diff
(100 %id)
R82410 placenta ARFGEF1.c 2734 to 3061 17 to 355       339/375
(90 %)
13 diff
(96.6 %id)
AA876416 2 pooled tumors (clear cell type), Kidney ARFGEF1.c 2751 to 3105 358 to 4       355/358
(99 %)
0 diff
(100 %id)
AW473248 serous papillary carcinoma, high grade, 2pooled tumors, uterus ARFGEF1.c 2761 to 3104 344 to 1       344/344
(100 %)
1 diff
(99.8 %id)
BF897108 marrow ARFGEF1.c 2774 to 3160 1 to 399       399/399
(100 %)
30 diff
(92.5 %id)
W44774 parathyroid gland, parathyroid tumor ARFGEF1.c 2792 to 3100 354 to 42   fully sequenced,   313/354
(88 %)
1 diff
(99.8 %id)
BI008538 kidney_tumor ARFGEF1.c 2855 to 3376 521 to 1       521/521
(100 %)
9 diff
(98.3 %id)
BG572971 placenta ARFGEF1.c 2891 to 3560 1 to 662       662/662
(100 %)
11 diff
(98.4 %id)
BF692261 melanotic melanoma, high MDR, skin ARFGEF1.c 2915 to 3510 1 to 589       589/883
(66 %)
9 diff
(99.0 %id)
TI_149309708   ARFGEF1.c 2930 to 3792 944 to 92   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 853/945
(90 %)
20 diff
(97.9 %id)
TI_149299076   ARFGEF1.c 2936 to 3792 937 to 89   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 849/940
(90 %)
14 diff
(98.6 %id)
FN174721 breast carcinoma ARFGEF1.c 2975 to 3046 1 to 72       72/72
(100 %)
2 diff
(97.3 %id)
BE827106 lung_tumor ARFGEF1.c 2986 to 3114 1 to 127       127/127
(100 %)
4 diff
(96.9 %id)
AI953661 Kidney ARFGEF1.c 2988 to 3541 554 to 1       554/554
(100 %)
0 diff
(100 %id)
BE827089 lung_tumor ARFGEF1.c 2990 to 3114 17 to 139       123/139
(88 %)
6 diff
(95.7 %id)
FN153435 breast carcinoma ARFGEF1.c 3007 to 3105 97 to 1     Submitted on the opposite strand 97/97
(100 %)
2 diff
(98.0 %id)
BU688085 lung ARFGEF1.c 3015 to 3792 795 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 778/778
(100 %)
4 diff
(99.5 %id)
BM975553 lung, Primary Lung Cystic Fibrosis EpithelialCells ARFGEF1.c 3018 to 3792 794 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 776/776
(100 %)
2 diff
(99.8 %id)
AW959733   ARFGEF1.c 3049 to 3540 553 to 65   AAA Submitted on the opposite strand 489/489
(100 %)
20 diff
(96.0 %id)
AA477576.
matches multiple genes
ovarian tumor, ovary ARFGEF1.c 3056 to 3642 1 to 587   tiling clone, also hits gene ESPN 587/587
(100 %)
0 diff
(100 %id)
BM992140 Bone, Subchondral Bone ARFGEF1.c 3149 to 3794 664 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 646/646
(100 %)
0 diff
(100 %id)
CA314908 Human Lung Epithelial cells, lung ARFGEF1.c 3150 to 3817 684 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 668/668
(100 %)
1 diff
(99.9 %id)
BG620917 placenta ARFGEF1.c 3177 to 3475 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
BQ005026 Chondrosarcoma, Left Pelvis ARFGEF1.c 3186 to 3794 627 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 609/609
(100 %)
6 diff
(99.1 %id)
FN046015 breast carcinoma ARFGEF1.c 3245 to 3355 111 to 1     Submitted on the opposite strand 111/111
(100 %)
2 diff
(98.2 %id)
AA437147   ARFGEF1.c 3249 to 3703 1 to 455       455/455
(100 %)
0 diff
(100 %id)
BM715117 eye, human retina ARFGEF1.c 3249 to 3801 1 to 554   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 554/554
(100 %)
1 diff
(99.9 %id)
CB049751 Prostate ARFGEF1.c 3267 to 3540 13 to 285   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 273/285
(95 %)
6 diff
(97.9 %id)
AI797847 B-cell, chronic lymphotic leukemia ARFGEF1.c 3289 to 3784 507 to 12       496/507
(97 %)
0 diff
(100 %id)
BE466025 pooled germ cell tumors ARFGEF1.c 3292 to 3793 508 to 7       502/508
(98 %)
0 diff
(100 %id)
BM665832 eye, human retina ARFGEF1.c 3293 to 3801 527 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 509/509
(100 %)
0 diff
(100 %id)
BE466034 pooled germ cell tumors ARFGEF1.c 3300 to 3776 503 to 25       479/503
(95 %)
0 diff
(100 %id)
AI917437 pooled germ cell tumors ARFGEF1.c 3302 to 3793 498 to 7       492/498
(98 %)
0 diff
(100 %id)
BF437842 Prostate ARFGEF1.c 3304 to 3540 254 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 237/237
(100 %)
0 diff
(100 %id)
CB217285 mandible, pooled ARFGEF1.c 3304 to 3792 526 to 37   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 490/490
(100 %)
0 diff
(100 %id)
CB049750 Prostate ARFGEF1.c 3306 to 3540 276 to 42   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 235/235
(100 %)
3 diff
(98.8 %id)
CB218905 mandible, pooled ARFGEF1.c 3311 to 3792 1 to 482   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 482/482
(100 %)
1 diff
(99.8 %id)
DB342197 thymus ARFGEF1.c 3311 to 3794 484 to 1       484/484
(100 %)
1 diff
(99.8 %id)
AW271473 Kidney ARFGEF1.c 3312 to 3794 497 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 483/483
(100 %)
3 diff
(99.4 %id)
AA298934 uterus ARFGEF1.c 3321 to 3540 220 to 1     Submitted on the opposite strand 220/220
(100 %)
3 diff
(98.7 %id)
AI368789 lung ARFGEF1.c 3324 to 3792 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AI632248 pooled germ cell tumors ARFGEF1.c 3337 to 3793 463 to 7       457/463
(98 %)
0 diff
(100 %id)
AW235911 pooled germ cell tumors ARFGEF1.c 3337 to 3795 462 to 4       459/462
(99 %)
0 diff
(100 %id)
FN173019 breast carcinoma ARFGEF1.c 3342 to 3445 102 to 1     Submitted on the opposite strand 102/102
(100 %)
4 diff
(96.1 %id)
BE551628 pooled germ cell tumors ARFGEF1.c 3362 to 3793 438 to 7       432/438
(98 %)
0 diff
(100 %id)
FN148112 breast carcinoma ARFGEF1.c 3365 to 3442 1 to 76       76/76
(100 %)
6 diff
(92.2 %id)
AA860154   ARFGEF1.c 3367 to 3795 431 to 3       429/431
(99 %)
0 diff
(100 %id)
BP224208 colon mucosa ARFGEF1.c 3383 to 3794 1 to 412   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 412/412
(100 %)
0 diff
(100 %id)
BP224343 colon mucosa ARFGEF1.c 3383 to 3794 1 to 412   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 412/412
(100 %)
0 diff
(100 %id)
AA860106   ARFGEF1.c 3383 to 3795 415 to 3       413/415
(99 %)
0 diff
(100 %id)
BY998977   ARFGEF1.c 3397 to 3795 1 to 399     Submitted on the opposite strand 399/401
(99 %)
5 diff
(98.8 %id)
AW993507 breast_normal ARFGEF1.c 3409 to 3677 9 to 277       269/277
(97 %)
7 diff
(97.5 %id)
AI220317 pooled ARFGEF1.c 3410 to 3795 388 to 3       386/388
(99 %)
0 diff
(100 %id)
AA833918 Kidney, kidney tumor ARFGEF1.c 3411 to 3797 387 to 1       387/387
(100 %)
4 diff
(99.0 %id)
H90433 liver and spleen ARFGEF1.c 3412 to 3771 370 to 1       370/370
(100 %)
10 diff
(97.3 %id)
AI439231 lymph node, lymphoma, follicular mixed small and largecell ARFGEF1.c 3431 to 3795 367 to 3       365/367
(99 %)
0 diff
(100 %id)
AI719279 aorta ARFGEF1.c 3432 to 3785 363 to 10       354/363
(97 %)
0 diff
(100 %id)
R22862 placenta ARFGEF1.c 3442 to 3539 1 to 98       98/98
(100 %)
0 diff
(100 %id)
R65938 placenta ARFGEF1.c 3442 to 3754 1 to 320       320/320
(100 %)
10 diff
(96.9 %id)
FN134957 breast carcinoma ARFGEF1.c 3443 to 3551 105 to 1     Submitted on the opposite strand 105/105
(100 %)
4 diff
(96.2 %id)
R82354 placenta ARFGEF1.c 3458 to 3791 338 to 1       338/338
(100 %)
10 diff
(97.1 %id)
AI800247 Kidney ARFGEF1.c 3459 to 3794 359 to 24   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 336/336
(100 %)
2 diff
(99.5 %id)
FN072040 breast carcinoma ARFGEF1.c 3462 to 3526 68 to 1     Submitted on the opposite strand 68/72
(94 %)
4 diff
(94.5 %id)
R36917 whole brain ARFGEF1.c 3481 to 3793 338 to 22   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 317/317
(100 %)
5 diff
(98.5 %id)
FN165280 breast carcinoma ARFGEF1.c 3513 to 3618 1 to 105       105/105
(100 %)
1 diff
(99.1 %id)
BG475644 melanotic melanoma, skin ARFGEF1.c 3526 to 3793 1 to 268   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 268/268
(100 %)
1 diff
(99.7 %id)
FN060892 breast carcinoma ARFGEF1.c 3530 to 3630 1 to 101       101/101
(100 %)
0 diff
(100 %id)
FN074603 breast carcinoma ARFGEF1.c 3531 to 3630 1 to 100       100/100
(100 %)
4 diff
(96.0 %id)
N63362 cochlea, ear ARFGEF1.c 3555 to 3794 241 to 1       241/241
(100 %)
1 diff
(99.6 %id)
AA766871 germinal center B cell ARFGEF1.c 3556 to 3793 252 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 238/238
(100 %)
0 diff
(100 %id)
BM822103 stomach ARFGEF1.c 3557 to 3806 1 to 250   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 250/250
(100 %)
6 diff
(97.6 %id)
FN153195 breast carcinoma ARFGEF1.c 3558 to 3657 1 to 100       100/103
(97 %)
3 diff
(97.1 %id)
AI198668   ARFGEF1.c 3560 to 3794 271 to 37   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 235/244
(96 %)
0 diff
(100 %id)
AI015733   ARFGEF1.c 3575 to 3795 223 to 3       221/223
(99 %)
0 diff
(100 %id)
BY999145   ARFGEF1.c 3583 to 3799 187 to 403     Submitted on the opposite strand 344/403
(85 %)
13 diff
(96.8 %id)
H90297 liver and spleen ARFGEF1.c 3586 to 3771 188 to 1       188/193
(97 %)
2 diff
(99.0 %id)
AI638366 pooled germ cell tumors ARFGEF1.c 3600 to 3793 194 to 1       194/194
(100 %)
3 diff
(98.5 %id)
BE887178 leiomyosarcoma, uterus ARFGEF1.c 3603 to 3777 308 to 494       471/523
(90 %)
33 diff
(93.7 %id)
N92915 lung ARFGEF1.c 3639 to 3793 186 to 32   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 155/155
(100 %)
0 diff
(100 %id)
BI059798 uterus_tumor ARFGEF1.d 1 to 307 307 to 1   tiling clone,   307/514
(59 %)
5 diff
(99.1 %id)
BQ722921 sympathetic trunk ARFGEF1.d 55 to 831 1 to 784   tiling clone,   784/913
(85 %)
30 diff
(96.8 %id)
BF338413 brain, glioblastoma with EGFR amplification ARFGEF1.d 466 to 1215 1 to 743   tiling clone,   743/931
(79 %)
22 diff
(97.7 %id)
DB042447 testis ARFGEF1.d 513 to 1063 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
AA079467   ARFGEF1.d 535 to 940 1 to 415       415/415
(100 %)
11 diff
(97.4 %id)
CX754208 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass ARFGEF1.d 582 to 1378 1 to 788     Submitted on the opposite strand 788/839
(93 %)
20 diff
(97.7 %id)
BP196672 adrenal gland ARFGEF1.d 583 to 1165 1 to 583       583/583
(100 %)
0 diff
(100 %id)
AL117446 testis ARFGEF1.d 610 to 2509 1 to 1900   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1900/1900
(100 %)
0 diff
(100 %id)
AA079468   ARFGEF1.d 1414 to 1823 414 to 5       410/414
(99 %)
0 diff
(100 %id)
BG992450 head_neck ARFGEF1.e 1 to 646 683 to 38 A9P Q59P N91H K105Q N109H ... tiling clone,   646/683
(94 %)
7 diff
(99.0 %id)
BE910622 epithelioid carcinoma, Pancreas ARFGEF1.f 1 to 701 1 to 704 exact tiling clone,   704/960
(73 %)
15 diff
(98.5 %id)
TI_149287319   ARFGEF1.f 244 to 932 769 to 81   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 689/1111
(62 %)
3 diff
(99.8 %id)
BM972659 lung ARFGEF1.f 310 to 932 641 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 623/623
(100 %)
0 diff
(100 %id)
AA682207 schizophrenic brain S-11 frontal lobe ARFGEF1.f 351 to 762 413 to 2       412/413
(99 %)
0 diff
(100 %id)
AI673077 thymus, pooled ARFGEF1.f 372 to 932 563 to 1       563/563
(100 %)
4 diff
(99.3 %id)
FN068410 breast carcinoma ARFGEF1.f 478 to 553 1 to 74       74/85
(87 %)
2 diff
(97.7 %id)
AW173710 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus ARFGEF1.f 550 to 967 418 to 1   tiling clone,   418/418
(100 %)
0 diff
(100 %id)
AW804678 uterus ARFGEF1.g 1 to 509 9 to 521   tiling clone,   513/521
(98 %)
6 diff
(98.9 %id)
DA809409 brain ARFGEF1.g 343 to 823 2 to 482   tiling clone, capped   481/481
(100 %)
0 diff
(100 %id)
BU561735 testis ARFGEF1.g 2097 to 2825 1 to 734   tiling clone,   734/763
(96 %)
8 diff
(99.0 %id)
DB327324 brain ARFGEF1.g 3644 to 4186 545 to 1   tiling clone,   545/545
(100 %)
2 diff
(99.7 %id)
BP240953 Liver ARFGEF1.h 1 to 574 1 to 574 exact tiling clone,   574/574
(100 %)
1 diff
(99.9 %id)
AI950186 pooled germ cell tumors ARFGEF1.h 461 to 971 515 to 4       512/515
(99 %)
0 diff
(100 %id)
BE672865 pooled germ cell tumors ARFGEF1.h 479 to 975 497 to 1       497/497
(100 %)
0 diff
(100 %id)
AA781249 parathyroid gland, parathyroid tumor ARFGEF1.h 573 to 981 409 to 1   tiling clone,   409/409
(100 %)
0 diff
(100 %id)
AA771856 parathyroid gland, parathyroid tumor ARFGEF1.h 771 to 981 211 to 1       211/211
(100 %)
0 diff
(100 %id)
DA105021 cerebellum ARFGEF1.i 1 to 579 2 to 580   tiling clone, capped   579/579
(100 %)
1 diff
(99.9 %id)
CB988744 Human Placenta, placenta ARFGEF1.i 323 to 1082 27 to 800       774/801
(96 %)
17 diff
(97.9 %id)
AL596887   ARFGEF1.i 474 to 1093 1 to 620   tiling clone,   620/620
(100 %)
4 diff
(99.4 %id)
DB221346 trachea ARFGEF1.i 951 to 1494 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
AK123660 brain ARFGEF1.i 1034 to 4212 1 to 3181 exact tiling clone, available from FLJ,   3181/3181
(100 %)
2 diff
(100.0 %id)
DA534033 brain ARFGEF1.i 1035 to 1580 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BU146212 dorsal root ganglia ARFGEF1.i 1823 to 2742 1 to 933   tiling clone,   933/942
(99 %)
30 diff
(96.9 %id)
CB155893 brain ARFGEF1.i 2061 to 2656 1 to 598       598/598
(100 %)
1 diff
(99.9 %id)
BQ022425 placenta ARFGEF1.i 2199 to 2672 1 to 479     Submitted on the opposite strand 479/479
(100 %)
5 diff
(99.0 %id)
BF380371 uterus_tumor ARFGEF1.i 2272 to 2737 14 to 479       466/479
(97 %)
6 diff
(98.8 %id)
BM923948 pooled colon, kidney, stomach ARFGEF1.i 2606 to 3613 1 to 1009       1009/1011
(99 %)
17 diff
(98.4 %id)
DB317832 brain ARFGEF1.i 3674 to 4212 539 to 1       539/539
(100 %)
0 diff
(100 %id)
CN284533 embryonic stem cells, cell lines H1, H7, andH9 ARFGEF1.j 1 to 160 1 to 160   tiling clone,   160/160
(100 %)
1 diff
(99.4 %id)
BF378053 testis_normal ARFGEF1.j 108 to 298 10 to 201   tiling clone,   192/201
(95 %)
6 diff
(97.1 %id)
AW368228 head_neck ARFGEF1.j 142 to 730 1 to 590 L62A R63A I64H L65S F66L ... tiling clone,   590/590
(100 %)
9 diff
(98.5 %id)
AI381569 pooled ARFGEF1.k 1 to 461 1 to 461     Submitted on the opposite strand 461/461
(100 %)
1 diff
(99.8 %id)
AI523655 B-cell, chronic lymphotic leukemia ARFGEF1.k 1 to 461 1 to 461   tiling clone, Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
BE675791 B-cell, chronic lymphotic leukemia ARFGEF1.k 1 to 571 1 to 571 F74C L112X tiling clone, Submitted on the opposite strand 571/571
(100 %)
1 diff
(99.9 %id)
AA805406 germinal center B cell ARFGEF1.k 25 to 308 1 to 276     Submitted on the opposite strand 276/276
(100 %)
10 diff
(96.4 %id)
BF374854 stomach ARFGEF1.l 1 to 551 554 to 4 N29Y tiling clone,   551/557
(98 %)
1 diff
(99.9 %id)
BM991497 lung, Metastatic Chondrosarcoma ARFGEF1.m 1 to 378 396 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 378/378
(100 %)
1 diff
(99.8 %id)
BX490969   ARFGEF1.n-u 1 to 573 9 to 582 exact tiling clone,   574/582
(98 %)
6 diff
(99.0 %id)
AW850187 colon ARFGEF1.n-u 200 to 854 1 to 655 exact tiling clone,   655/656
(99 %)
1 diff
(99.9 %id)
BF894046 marrow ARFGEF1.n-u 584 to 846 275 to 8     Submitted on the opposite strand 268/278
(96 %)
0 diff
(100 %id)
BG015797 placenta_normal ARFGEF1.n-u 702 to 1063 369 to 9       361/369
(97 %)
0 diff
(100 %id)
BI039091 nervous_tumor ARFGEF1.n-u 776 to 1238 1 to 463   tiling clone,   463/463
(100 %)
8 diff
(98.3 %id)
BF447965 Kidney ARFGEF1.n-u 987 to 1480 494 to 1   tiling clone,   494/494
(100 %)
1 diff
(99.8 %id)
BQ708265 Spleen ARFGEF1.o-u 1 to 804 1 to 810 exact tiling clone,   810/1006
(80 %)
13 diff
(98.8 %id)
BG745826 Spleen ARFGEF1.o-u 354 to 1101 1137 to 361   tiling clone,   777/1137
(68 %)
0 diff
(100 %id)
BQ897108 dorsal root ganglia ARFGEF1.p-u 1 to 837 32 to 879 exact tiling clone,   848/952
(89 %)
13 diff
(98.7 %id)
DA854775.
matches multiple genes
placenta ARFGEF1.q-u 160 to 739 2 to 585 exact tiling clone, capped also hits gene PRR13andPCBP2 584/584
(100 %)
2 diff
(99.7 %id)
DA372003 thalamus ARFGEF1.r 1 to 556 2 to 556 G6V F7S L8S T9Q E10N ... tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
BE552443 Kidney ARFGEF1.s 1 to 550 1 to 550 exact tiling clone, Submitted on the opposite strand 550/551
(99 %)
1 diff
(99.9 %id)
BQ318424 colon ARFGEF1.t-u 1 to 453 486 to 21 exact tiling clone,   461/492
(93 %)
0 diff
(100 %id)
BE149394 head_neck ARFGEF1.u-u 1 to 326 21 to 346 exact tiling clone,   326/346
(94 %)
6 diff
(98.3 %id)
AW855978 colon ARFGEF1.va-u 1 to 319 9 to 328 S27L T29I S31F Y40S C41G ... tiling clone,   320/342
(93 %)
23 diff
(93.3 %id)
AV693293 hepatocellular carcinoma Gene ARFGEF1, variant not shown         Suspected internal deletion, this clone was ignored    
TI_151797115   Gene ARFGEF1, variant not shown         Submitted on the opposite strand    
AV696421 hepatocellular carcinoma Gene ARFGEF1, variant not shown         Suspected internal deletion, this clone was ignored    
BF801085 colon_ins Gene ARFGEF1, variant not shown              
AK127799 brain Gene ARFGEF1, variant not shown       available from FLJ, This clone was ignored    
DB305317 brain Gene ARFGEF1, variant not shown              
DA228311 brain Gene ARFGEF1, variant not shown       capped      
N36996 melanocyte Gene ARFGEF1, variant not shown         This clone was ignored    
N46309 melanocyte Gene ARFGEF1, variant not shown         This clone was ignored    
BF243934 bone marrow, from acute myelogenous leukemia Gene ARFGEF1, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o-u, .p-u, .q-u, .r, .s, .t-u, .u-u, .va-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI